Skip to main content

Table 2 Acute (defined as within 90 days of radiation treatment) and late (greater than 90 days after radiation treatment) toxicities after radiotherapy, as quantified by CTCAE schema

From: Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer

  Acute toxicities Late toxicities
Dysgeusia   
 Grade 0 4 (12%) 4 (12%)
 Grade 1 19 (56%) 22 (65%)
 Grade 2 11 (32%) 8 (24%)
 Grade 3 0 (0%) 0 (0%)
Dysphagia   
 Grade 0 1 (3%) 4 (12%)
 Grade 1 18 (53%) 11 (32%)
 Grade 2 11 (32%) 14 (41%)
 Grade 3 4 (12%) 5 (15%)
Pain   
 Grade 0 1 (3%) 4 (12%)
 Grade 1 8 (24%) 14 (41%)
 Grade 2 21 (62%) 14 (41%)
 Grade 3 4 (12%) 2 (6%)
Xerostomia   
 Grade 0 0 (0%) 0 (0%)
 Grade 1 17 (50%) 27 (79%)
 Grade 2 17 (50%) 7 (21%)
 Grade 3 0 (0%) 0 (0%)